Contents
Aisling Capital is a venture capital and private equity firm investing in healthcare and biotechnology companies that is headquartered in New York City, New York and was founded in 2000.
Investments
The firms invests primarily in companies commercializing healthcare products, services, and technologies. Aisling Capital has raised about $1.8 billion in committed capital across 4 investment funds and has made 106 investments. Notable investments made by the firm include: Dermira, BridgeBio, Atreca, TransEnterix, ViewRay, T2 Biosystems, Arcus Biosciences, Aimmune Therapeutics, Eidos Therapeutics, and Avrobio.
Timeline
Invested in
Open in Query Tool
Patents
Open in Query Tool
Funding Rounds Participated In
Open in Query Tool
Further Resources
Title
Author
Link
Type
Date
References
Company attributes
Location
Founder
Full Address
888 SEVENTH AVENUE 12TH FLOOR NEW YORK, NY 10106
Founded Date
2000
Other attributes
Company Operating Status
Active
Country
